Spots Global Cancer Trial Database for medullary ductal breast carcinoma with lymphocytic infiltrate
Every month we try and update this database with for medullary ductal breast carcinoma with lymphocytic infiltrate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | NCT01706432 | Central Nervous... Invasive Ductal... Invasive Ductal... Invasive Lobula... Invasive Lobula... Liver Metastase... Lobular Breast ... Lung Metastases Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Recurrent Breas... Stage IV Breast... Tubular Ductal ... Tumors Metastat... | hyperfractionat... laboratory biom... stereotactic ra... | 18 Years - | University of Chicago | |
| Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | NCT00002873 | Breast Cancer | brachytherapy | - | Radiation Therapy Oncology Group | |
| Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | NCT02186470 | Estrogen Recept... Invasive Ductal... Invasive Ductal... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Stage IA Breast... Stage IB Breast... Tubular Ductal ... | accelerated par... intensity-modul... image-guided ra... therapeutic con... | 50 Years - | Ohio State University Comprehensive Cancer Center | |
| Radiation Therapy in Treating Women With Early Stage Breast Cancer | NCT00909909 | Breast Cancer | External beam b... whole breast ir... | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer | NCT00599989 | Breast Cancer Long-term Effec... Skin Reactions ... | adjuvant therap... conventional su... 3-dimensional c... brachytherapy intracavitary b... proton beam rad... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Radiation Therapy in Treating Patients With Recurrent Breast Cancer | NCT00945061 | Breast Cancer | intracavitary b... intraoperative ... | 18 Years - | Case Comprehensive Cancer Center | |
| Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery | NCT01082211 | Breast Cancer | 3D-Conformal Ex... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer | NCT00295893 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... Trastuzumab Carboplatin Paclitaxel | 18 Years - 120 Years | City of Hope Medical Center | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer | NCT00599989 | Breast Cancer Long-term Effec... Skin Reactions ... | adjuvant therap... conventional su... 3-dimensional c... brachytherapy intracavitary b... proton beam rad... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer | NCT00527293 | Breast Cancer | adjuvant therap... 3-dimensional c... brachytherapy | 18 Years - | Case Comprehensive Cancer Center | |
| Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | NCT00002873 | Breast Cancer | brachytherapy | - | Radiation Therapy Oncology Group | |
| Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer | NCT00749437 | Breast Cancer | 3-dimensional c... | 45 Years - | Rutgers, The State University of New Jersey | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer | NCT00527293 | Breast Cancer | adjuvant therap... 3-dimensional c... brachytherapy | 18 Years - | Case Comprehensive Cancer Center | |
| Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | NCT02186470 | Estrogen Recept... Invasive Ductal... Invasive Ductal... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Stage IA Breast... Stage IB Breast... Tubular Ductal ... | accelerated par... intensity-modul... image-guided ra... therapeutic con... | 50 Years - | Ohio State University Comprehensive Cancer Center | |
| Radiation Therapy in Treating Patients With Recurrent Breast Cancer | NCT00945061 | Breast Cancer | intracavitary b... intraoperative ... | 18 Years - | Case Comprehensive Cancer Center | |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | NCT00182793 | Breast Cancer | trastuzumab carboplatin cyclophosphamid... melphalan thiotepa adjuvant therap... autologous-auto... bone marrow abl... radiation thera... | - 65 Years | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
